# Runway Growth Finance Corp.: overview RWAY · Nasdaq · CIK 1653384 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/rway.md) · [Financials](/companies/rway/financials.md) · [Filings](/companies/rway/filings.md) · [Insiders](/companies/rway/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.65](/filings/0001193125-25-269547.md) | not reported | [0.05](/filings/0001193125-26-211877.md) | [0.45](/filings/0001193125-26-337968.md) | [0.22](/filings/0001193125-25-269547.md) | not reported | [(0.96)](/filings/0001193125-26-211877.md) | [0.65](/filings/0001193125-26-337968.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.33](/filings/0000950170-24-027913.md) | [0.79](/filings/0000950170-25-042625.md) | [1.09](/filings/0001193125-26-104117.md) | [1.89](/filings/0001193125-26-104117.md) | [0.93](/filings/0001193125-26-104117.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/rway/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [OAKTREE CAPITAL MANAGEMENT LP](/funds/949509.md) | 2026-06-30 | $39.4m | 7,029,667 | | Unchanged | | [Sound Income Strategies, LLC](/funds/1730960.md) | 2026-06-30 | $11.2m | 2,003,042 | | Added +159,810 | | [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $8.5m | 1,517,179 | | Added +339,356 | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $7.5m | 1,343,131 | | Reduced −51,449 | | [Bulldog Investors, LLP](/funds/1504304.md) | 2026-06-30 | $5.7m | 1,019,054 | | Reduced −181,075 | | [North Ground Capital](/funds/2055446.md) | 2026-06-30 | $4.1m | 728,000 | | Reduced −233,326 | | [ALLIUM FINANCIAL ADVISORS, LLC](/funds/2067277.md) | 2026-06-30 | $4.0m | 715,665 | | Reduced −60,140 | | [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $3.2m | 573,697 | | Added +33,947 | | [Summit Financial, LLC](/funds/1765536.md) | 2026-06-30 | $3.0m | 543,246 | | Added +15,255 | | [Alpine Global Management, LLC](/funds/1581655.md) | 2026-06-30 | $2.8m | 500,192 | | Reduced −181,059 | ## Recent filings [All 477 filings](/companies/rway/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-13 | 12:30 ET | [8-K](/filings/0001193125-26-419756.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-419756 | | 2026-10-01 | 20:15 ET | [8-K](/filings/0001193125-26-410679.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-410679 | | 2026-09-25 | 21:00 ET | [8-K](/filings/0001193125-26-402956.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-402956 | | 2026-08-06 | 20:08 ET | [10-Q](/filings/0001193125-26-337968.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337968 | | 2026-08-06 | 20:05 ET | [8-K](/filings/0001193125-26-337951.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337951 | | 2026-08-05 | 20:05 ET | [8-K](/filings/0001193125-26-335031.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-335031 | | 2026-07-15 | 20:49 ET | [8-K](/filings/0001193125-26-304889.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-304889 | | 2026-07-14 | 12:30 ET | [8-K](/filings/0001193125-26-302607.md) | 7.01 Regulation FD disclosure | 0001193125-26-302607 | | 2026-06-25 | 20:00 ET | [8-K](/filings/0001193125-26-282711.md) | 5.07 Shareholder vote results | 0001193125-26-282711 | | 2026-05-29 | 20:17 ET | [8-K](/filings/0001104659-26-068282.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-068282 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-104117.md), filed Mar 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1653384 - Tickers: RWAY, RWAYI, RWAYL, RWAYM - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.